COMMONWEALTH EQUITY SERVICES, LLC
Position in NTLA — Intellia Therapeutics, Inc.
CIK 312272
WALTHAM, MA
Position in NTLA
as of Mar 31, 2026
· filed Apr 27, 2026
Position Value
$1,207,464
+$364,104 QoQ
Shares Held
94,186
+0.4% QoQ
Ownership
0.067%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Common Shares in NTLA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026COMMONWEALTH EQUITY SERVICES, LLC holds $113,564,491 across 120 Biotechnology names. NTLA ranks #20 (1.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
54,972 | $24,547,196 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
16,385 | $12,659,706 | |
| 3 | EXEL |
Exelixis, Inc.
|
173,762 | $7,452,652 | |
| 4 | TGTX |
Tg Therapeutics, Inc.
|
180,285 | $5,989,067 | |
| 5 | TARS |
Tarsus Pharmaceuticals, Inc.
|
80,892 | $5,674,573 | |
| 6 | CRSP |
CRISPR Therapeutics AG
|
78,488 | $3,733,674 | |
| 7 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
10,577 | $3,499,611 | |
| 8 | ARWR |
Arrowhead Pharmaceuticals, Inc.
|
55,076 | $3,453,265 |
All Filings in NTLA
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,207,464 | 94,186 | Shares | Sole | 2026-04-27 | |
| 2025-12-31 | $843,360 | 93,811 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $1,548,065 | 89,639 | Shares | Sole | 2025-10-22 | |
| 2025-06-30 | $630,279 | 67,194 | Shares | Sole | 2025-08-06 | |
| 2025-03-31 | $300,489 | 42,263 | Shares | Sole | 2025-05-09 | |
| 2024-12-31 | $358,708 | 30,764 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $501,851 | 24,421 | Shares | Sole | 2024-10-18 | |
| 2024-06-30 | $616,278 | 27,537 | Shares | Sole | 2024-07-31 | |
| 2024-03-31 | $951,653 | 34,593 | Shares | Sole | 2024-04-29 | |
| 2023-12-31 | $992,723 | 32,559 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $961,722 | 30,415 | Shares | Sole | 2023-10-23 | |
| 2023-06-30 | $1,162,433 | 28,505 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $1,055,076 | 28,309 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $948,519 | 27,186 | Shares | Sole | 2023-02-07 | |
| 2022-09-30 | $1,039,289 | 18,572 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $1,087,218 | 21,005 | Shares | Sole | 2022-07-19 | |
| 2022-03-31 | $1,880,336 | 25,875 | Shares | Sole | 2022-05-04 | |
| 2021-12-31 | $3,142,700 | 26,579 | Shares | Sole | 2022-01-31 | |
| 2021-09-30 | $3,541,157 | 26,397 | Shares | Sole | 2021-10-29 | |
| 2021-06-30 | $4,389,380 | 27,110 | Shares | Sole | 2021-08-11 | |
| 2021-03-31 | $1,986,953 | 24,758 | Shares | Sole | 2021-05-04 | |
| 2020-12-31 | $1,336,009 | 24,559 | Shares | Sole | 2021-02-11 | |
| 2020-09-30 | $480,479 | 24,169 | Shares | Sole | 2020-11-05 | |
| 2020-06-30 | $502,882 | 23,924 | Shares | Sole | 2020-08-12 | |
| 2020-03-31 | $358,803 | 29,338 | Shares | Sole | 2020-05-11 | |
| No filing history on record for this holder in this stock. | ||||||